Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,389,629 papers from all fields of science
Search
Sign In
Create Free Account
Sandimmune
Known as:
Sandimmun
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Cyclosporine
Cyclosporine 25 MG Oral Capsule [Sandimmune]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
J. Kobashigawa
,
Jignesh K. Patel
,
+10 authors
H. Laks
The Journal of Heart and Lung Transplantation
2006
Corpus ID: 21970817
Review
2005
Review
2005
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
R. Woodroffe
,
G. Yao
,
+4 authors
R. Taylor
Health Technology Assessment
2005
Corpus ID: 39833980
OBJECTIVES To examine the clinical effectiveness and cost-effectiveness of the newer immunosuppressive drugs for renal…
Expand
Highly Cited
2002
Highly Cited
2002
Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats.
S. Hsiu
,
Yu-Chi Hou
,
Yao-Horng Wang
,
C. Tsao
,
S. Su
,
P. Chao
Life Science
2002
Corpus ID: 10340955
Highly Cited
2001
Highly Cited
2001
Bioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheres.
Eun-Jin Lee
,
Sa-Won Lee
,
Han-Gon Choi
,
Chong-Kook Kim
International journal of pharmaceutics
2001
Corpus ID: 22487655
Highly Cited
1999
Highly Cited
1999
Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.
B. Kahan
,
Bruce A. Julian
,
M. Pescovitz
,
Y. Vanrenterghem
,
J. Neylan
Transplantation
1999
Corpus ID: 22673111
BACKGROUND The novel agent sirolimus (SRL; Rapamune; rapamycin) inhibits the immune response by a mechanism distinct from those…
Expand
Highly Cited
1998
Highly Cited
1998
A randomized, double‐blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis
J. Koo
,
J. Bos
British Journal of Dermatology
1998
Corpus ID: 70578024
This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun® and Neoral®, in patients…
Expand
Highly Cited
1997
Highly Cited
1997
Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun.
V. Lamarque
,
M. Leleu
,
C. Monka
,
P. Krupp
Transplantation Proceedings
1997
Corpus ID: 26866141
Highly Cited
1995
Highly Cited
1995
Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion.
A. Trull
,
K. Tan
,
L. Tan
,
G. Alexander
,
N. Jamieson
British Journal of Clinical Pharmacology
1995
Corpus ID: 43696635
1. Less than 5% of a dose of the conventional oral formulation of cyclosporin, Sandimmun, is absorbed in liver transplant…
Expand
Review
1992
Review
1992
Consensus Conference on cyclosporin A for psoriasis February 1992
M. Mihatsch
,
K. Wolff
British Journal of Dermatology
1992
Corpus ID: 7756833
Summary Human studies using oral cyclosporin A (CyA; Sandimmun®) therapy for psoriasis have been in progress for nearly 9 years…
Expand
Highly Cited
1989
Highly Cited
1989
Cyclosporins--new analogues by precursor directed biosynthesis.
Rene Traber
,
Hans Hofmann
,
Hans Kobel
Journal of antibiotics (Tokyo. )
1989
Corpus ID: 10395516
Cyclosporin A (ciclosporin), a potent and clinically important immunosuppressive drug (Sandimmun), represents the main component…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE